Literature DB >> 10831070

Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptor.

T Domagala1, N Konstantopoulos, F Smyth, R N Jorissen, L Fabri, D Geleick, I Lax, J Schlessinger, W Sawyer, G J Howlett, A W Burgess, E C Nice.   

Abstract

The kinetics, binding equilibria and stoichiometry of the interaction between epidermal growth factor and the soluble extracellular domain of the epidermal growth factor receptor (sEGFR), produced in CHO cells using a bioreactor, have been studied by three methods: analytical ultracentrifugation, biosensor analysis using surface plasmon resonance detection (BIAcore 2000) and fluorescence anisotropy. These studies were performed with an sEGFR preparation purified in the absence of detergent using a mild two step chromatographic procedure employing anion exchange and size exclusion HPLC. The fluorescence anisotropy and analytical ultracentrifugation data indicated a 1:1 molar binding ratio between EGF and the sEGFR. Analytical ultracentrifugation further indicated that the complex comprised 2EGF:2sEGFR, consistent with the model proposed recently by Lemmon et al. (1997). Global analysis of the BIAcore binding data showed that a simple Langmuirian interaction does not adequately describe the EGF:sEGFR interaction and that more complex interaction mechanisms are operative. Furthermore, analysis of solution binding data using either fluorescence anisotropy or the biosensor, to determine directly the concentration of free sEGFR in solution competition experiments, yielded Scatchard plots which were biphasic and Hill coefficients of less than unity. Taken together our data indicate that in solution there are two sEGFR populations; one which binds EGF with a KD of 2-20 nM and the other with a KD of 400-550 nM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831070     DOI: 10.3109/08977190009003231

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  8 in total

1.  The development of quantum dot calibration beads and quantitative multicolor bioassays in flow cytometry and microscopy.

Authors:  Yang Wu; Samuel K Campos; Gabriel P Lopez; Michelle A Ozbun; Larry A Sklar; Tione Buranda
Journal:  Anal Biochem       Date:  2007-02-13       Impact factor: 3.365

2.  Critical roles for EGFR and EGFR-HER2 clusters in EGF binding of SW620 human carcinoma cells.

Authors:  Adam J M Wollman; Charlotte Fournier; Isabel Llorente-Garcia; Oliver Harriman; Alex L Payne-Dwyer; Sviatlana Shashkova; Peng Zhou; Ta-Chun Liu; Djamila Ouaret; Jenny Wilding; Akihiro Kusumi; Walter Bodmer; Mark C Leake
Journal:  J R Soc Interface       Date:  2022-05-25       Impact factor: 4.293

3.  Characterization of glycosylation sites of the epidermal growth factor receptor.

Authors:  Yuejun Zhen; Richard M Caprioli; James V Staros
Journal:  Biochemistry       Date:  2003-05-13       Impact factor: 3.162

4.  Interactions between anti-ErbB2 antibody A21 and the ErbB2 extracellular domain provide a basis for improving A21 affinity.

Authors:  Liang Chang; Changhai Zhou; Man Xu; Jing Liu
Journal:  J Comput Aided Mol Des       Date:  2009-12-12       Impact factor: 3.686

Review 5.  Ligand-induced ErbB receptor dimerization.

Authors:  Mark A Lemmon
Journal:  Exp Cell Res       Date:  2008-10-31       Impact factor: 3.905

6.  The significance of disulfide bonding in biological activity of HB-EGF, a mutagenesis approach.

Authors:  J T Hoskins; Z Zhou; P A Harding
Journal:  Biochem Biophys Res Commun       Date:  2008-08-24       Impact factor: 3.575

7.  A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis.

Authors:  M Lindzen; S Carvalho; A Starr; N Ben-Chetrit; C-R Pradeep; W J Köstler; A Rabinkov; S Lavi; S S Bacus; Y Yarden
Journal:  Oncogene       Date:  2011-11-21       Impact factor: 9.867

8.  Probing the Kinetic and Thermodynamic Fingerprints of Anti-EGF Nanobodies by Surface Plasmon Resonance.

Authors:  Salvador Guardiola; Monica Varese; Marta Taulés; Mireia Díaz-Lobo; Jesús García; Ernest Giralt
Journal:  Pharmaceuticals (Basel)       Date:  2020-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.